Disorder at the Start: The Contribution of Dysregulated Translation Initiation to Cancer Therapy Resistance

Gulshan Sunavala-Dossabhoy1

  • 1Department of Biochemistry and Molecular Biology, Louisiana State University Health and Feist Weiller Cancer Center, Shreveport, LA, United States.

Frontiers in Oral Health
|January 20, 2022
PubMed

Insights

Cellular RNA translation into protein is regulated and essential for cell function. Deregulation of this process, particularly at the Tousled-like kinase 1 (TLK1) gene, contributes to cancer and treatment resistance.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Cellular RNA translation into protein is a fundamental, energy-intensive process.
  • This translation is tightly regulated by extracellular signals and intracellular amino acid availability.
  • The 5' methyl 7-guanosine (m7G) cap is crucial for mRNA recruitment of the translation machinery in eukaryotes.

Purpose of the Study:

  • To provide an overview of mammalian translation initiation.
  • To discuss the primary regulatory mechanisms of translation.
  • To explore how deregulation of translation initiation contributes to tumorigenesis and treatment resistance, focusing on TLK1.

Main Methods:

  • Literature review of mammalian translation initiation.
  • Analysis of regulatory mechanisms governing translation.
  • Discussion of the role of aberrant translation initiation in cancer, specifically TLK1 downstream ORF initiation.

Main Results:

  • Translation initiation is a key regulatory point in gene expression.
  • Dysregulation of translation initiation is implicated in cancer development.
  • Initiation at a downstream open reading frame (ORF) of Tousled-like kinase 1 (TLK1) is linked to cancer treatment resistance.

Conclusions:

  • Understanding translation initiation regulation is vital for cancer biology.
  • Aberrant translation control, exemplified by TLK1, represents a significant mechanism in tumorigenesis and therapeutic failure.
  • Targeting translation initiation pathways may offer novel cancer treatment strategies.

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
35.2K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
16.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K